Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.80 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | FDPS | P14324 | 3/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA4 | P22748 | 2/20 | 0.32 |
| ▸ | CA5A | P35218 | 2/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.32 |
| ▸ | TYMS | P04818 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL19326716 | 1.00 | SLC34A1 (0.80) | SLC34A1LMNACA2KDM4ECYP2C19 | |
| Phosphoric Acid SCHEMBL7943344 | 1.00 | SLC34A1 (0.80) | SLC34A1LMNACA2KDM4ECYP2C19 | |
| Phosphoric Acid SCHEMBL74378 | 1.00 | SLC34A1 (0.80) | SLC34A1LMNACA2KDM4ECYP2C19 | |
| Phosphoric Acid SCHEMBL113721 | 0.95 | — | — | |
| Phosphoric Acid SCHEMBL119879 | 0.95 | — | — | |
| Phosphoric Acid SCHEMBL210340 | 0.95 | SLC34A1 (0.73) | SLC34A1LMNACA2KDM4ECYP2C19 | |
| Phosphoric Acid SCHEMBL7792643 | 0.95 | — | — | |
| Phosphoric Acid SCHEMBL193060 | 0.95 | SLC34A1 (0.73) | SLC34A1LMNACA2KDM4ECYP2C19 | |
| Phosphoric Acid SCHEMBL19086896 | 0.95 | SLC34A1 (0.73) | SLC34A1LMNACA2KDM4ECYP2C19 | |
| Phosphoric Acid SCHEMBL29581355 | 0.95 | SLC34A1 (0.73) | SLC34A1LMNACA2KDM4ECYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230263935-A1 | NON-FIXED TYPE IMPLANT FOR CRANIOTOMY AND METHOD OF MANUFACTURING SAME | T&R BIOFAB CO., LTD. (KR) | 2023-08-24 | — | — | US | claimed |
| EP-4190281-A1 | NON-FIXED TYPE IMPLANT FOR CRANIOTOMY AND METHOD OF MANUFACTURING SAME | T&R Biofab Co., Ltd. (KR) | 2023-06-07 | — | — | EP | claimed |
| US-20170142993-A1 | CREATINE-PROTEIN MATRIX AND METHOD FOR PRODUCING SAID MATRIX | ALZCHEM AG (DE) | 2017-05-25 | — | — | US | claimed |
| EP-2926669-B1 | Creatine protein matrix and method for manufacturing the same | ALZCHEM AG (DE) | 2017-05-24 | — | — | EP | claimed |
| EP-2720552-B1 | PROCESS FOR THE MANUFACTURE OF A LEAVENED FOODSTUFF AND AN APPARATUS THEREFOR | MACPHIE OF GLENBERVIE LTD (GB) | 2016-07-13 | — | — | EP | claimed |
| WO-2015150275-A1 | CREATINE-PROTEIN MATRIX AND METHOD FOR PRODUCING SAID MATRIX | ALZCHEM AG (DE) | 2015-10-08 | — | — | WO | claimed |
| EP-2926669-A1 | Creatine protein matrix and method for manufacturing the same | AlzChem AG (DE) | 2015-10-07 | — | — | EP | claimed |
| CN-109487323-A | A kind of electrolyte in surface of metal titanium differential arc oxidation preparation perforated membrane containing biological active elements | 大连理工大学 | 2019-03-19 | — | — | CN | disclosed |
| CN-109384210-A | A method of utilizing hydrochloric acid and Phosphate Rock acid calcium salt and calcium sulfate | 川恒生态科技有限公司 | 2019-02-26 | — | — | CN | disclosed |
| CN-105819769-B | A kind of preparation method of pervious cement soil | 东南大学 | 2018-05-04 | — | — | CN | disclosed |
| US-20170142993-A1 | CREATINE-PROTEIN MATRIX AND METHOD FOR PRODUCING SAID MATRIX | ALZCHEM AG (DE) | 2017-05-25 | — | — | US | disclosed |
| EP-2926669-B1 | Creatine protein matrix and method for manufacturing the same | ALZCHEM AG (DE) | 2017-05-24 | — | — | EP | disclosed |
| WO-2015150275-A1 | CREATINE-PROTEIN MATRIX AND METHOD FOR PRODUCING SAID MATRIX | ALZCHEM AG (DE) | 2015-10-08 | — | — | WO | disclosed |
| EP-2926669-A1 | Creatine protein matrix and method for manufacturing the same | AlzChem AG (DE) | 2015-10-07 | — | — | EP | disclosed |
| US-20080268045-A1 | SUSTAINED RELEASE METHOTREXATE FORMULATIONS AND METHODS OF USE THEREOF | PROPRIUS PHARMACEUTICALS, INC. (US) | 2008-10-30 | — | — | US | disclosed |
| WO-2008058288-A2 | SUSTAINED RELEASE METHOTREXATE FORMULATIONS AND METHODS OF USE THEREOF | PROPRIUS PHARMACEUTICALS, INC. (US) | 2008-05-15 | — | — | WO | disclosed |
| EP-1755697-A2 | COMPRESSED POROUS MATERIALS SUITABLE FOR IMPLANT | KENSEY NASH CORPORATION (US) | 2007-02-28 | — | — | EP | disclosed |
| WO-2005107829-A2 | COMPRESSED POROUS MATERIALS SUITABLE FOR IMPLANT | KENSEY NASH CORPORATION (US) | 2005-11-17 | — | — | WO | disclosed |
| US-6242004-B1 | CONTAINING POLYMER MODIFIED BY MALEIC ANHYDRIDE | PERMATEC TECHNOLOGIE AG (CH) | 2001-06-05 | — | — | US | disclosed |